At the same time, the judge declined to issue a compulsory license for the drug, an issue that prompted advocacy groups to file their lawsuit two years ago...Abbott was charging $400 in the world's poorest countries and between $1,000 and $4,000 in other developing nations ( see this ).
FULL ARTICLE AT Pharmalot